Fidelity International’s Vigil Neuroscience VIGL Stock Holding History

Fidelity International’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-558,762	Closed	-$4.44M	–	1056
2025 Q2	$4.44M	Buy	+558,762	New	+$2.5M	﹤0.01%	633

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Fidelity International's VIGL Position: Q3 2025 in Review

Fidelity International sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 558,762 shares — an estimated $4.44M sold.

Fidelity International first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $4.44M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Fidelity International reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Fidelity International sold 558,762 Vigil Neuroscience shares in Q3 2025, an estimated $4.44M.
Fidelity International first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Fidelity International's Vigil Neuroscience position peaked at $4.44M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.